Posted on Dec 17, 2020
Sacklers To Face House Panel Over Purdue Pharma Oxycontin Sales
1.15K
17
8
5
5
0
In a surprise development, two members of the Sackler family who served on Purdue Pharma's board until 2018 will testify Thursday morning under oath before the House Committee on Oversight and Reform.
Their privately owned company developed and aggressively marketed Oxycontin in the 1990s, growing into one of the nation's most profitable opioid producers.
David Sackler, Dr. Kathe Sackler and three other family members face a wave of civil lawsuits tied to their alleged role fueling the nation's addiction crisis.
Their privately owned company developed and aggressively marketed Oxycontin in the 1990s, growing into one of the nation's most profitable opioid producers.
David Sackler, Dr. Kathe Sackler and three other family members face a wave of civil lawsuits tied to their alleged role fueling the nation's addiction crisis.
Sacklers To Face House Panel Over Purdue Pharma Oxycontin Sales
Posted from npr.orgPosted in these groups: Purdue Pharma L.P.
Drugs
PharmaceuticalsU.S. House of Representatives
Congress
Drugs PharmaceuticalsU.S. House of Representatives Congress
Posted 4 y ago
Responses: 4
6
6
0
2
2
0
The guys that walk right in with a briefcase, while you're waiting a few hours to see a Dr. Free samples, open door.
(2)
(0)
2
2
0
These companies marketed to doctors as though these were not addictive substances.
(2)
(0)
Read This Next
Continue with Facebook 
Continue with Google